SureTrader
Home > Boards > US OTC > Biotechs > NorthWest Biotherapeutics Inc. (NWBO)

On the NWBO site: Annual Meeting Proxy Statement

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
H2R Member Profile
 
Followed By 13
Posts 1,068
Boards Moderated 0
Alias Born 07/17/14
160x600 placeholder
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/16/2018 5:23:28 PM
Small Company Offering and Sale of Securities Without Registration (d) "Edgar (US Regulatory)" - 1/10/2018 2:02:52 PM
Proxy Statement (definitive) (def 14a) "Edgar (US Regulatory)" - 1/9/2018 4:31:55 PM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 1/9/2018 12:25:11 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/5/2018 5:13:48 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/4/2018 4:29:59 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 12/21/2017 8:02:14 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 12/7/2017 4:33:36 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 12/5/2017 5:25:14 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/21/2017 6:05:58 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 11/20/2017 5:33:26 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) "Edgar (US Regulatory)" - 11/14/2017 5:20:39 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 10/24/2017 3:19:13 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/16/2017 5:28:13 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/22/2017 5:11:32 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/22/2017 4:18:34 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 9/22/2017 8:58:57 AM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 9/11/2017 2:46:27 PM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 9/11/2017 2:41:35 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 8/21/2017 4:40:00 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) "Edgar (US Regulatory)" - 8/15/2017 4:12:02 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/8/2017 5:28:51 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/7/2017 5:24:08 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 8/7/2017 5:19:53 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/7/2017 1:14:16 PM
H2R   Friday, 01/12/18 03:14:56 PM
Re: VuBru post# 153134
Post # of 153864 
On the NWBO site: Annual Meeting Proxy Statement

https://www.nwbio.com/Proxy-Statement-January-09-2018.pdf

I had not noticed it before today. Maybe some of you relayed the info already.

One item that may be of interest to some on this MB:
Quote:

Communication with the Board of Directors
We have established a procedure by which our stockholders may communicate directly with our Board. All communications should be in written form
and directed to our corporate secretary at the following address: Northwest Biotherapeutics, Inc., 4800 Montgomery Lane, Suite 800, Bethesda, Maryland
20814, Attention: Secretary, phone: (240) 497-9024.



And I'm writing by snail mail to ask about Ph III status, data, when can we hear, if not why, etc.

Good luck to Patients, NWBO, and Longs



Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist